Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Colorcon
QuintilesIMS
Farmers Insurance
Fuji
Accenture
Argus Health
Express Scripts
Cipla

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019580

« Back to Dashboard

NDA 019580 describes OSMOVIST 240, which is a drug marketed by Bayer Hlthcare and is included in one NDA. Additional details are available on the OSMOVIST 240 profile page.

The generic ingredient in OSMOVIST 240 is iotrolan. Additional details are available on the iotrolan profile page.
Summary for 019580
Tradename:OSMOVIST 240
Applicant:Bayer Hlthcare
Ingredient:iotrolan
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRATHECALStrength40.6%
Approval Date:Dec 7, 1989TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRATHECALStrength51.3%
Approval Date:Dec 7, 1989TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Julphar
UBS
Harvard Business School
Fish and Richardson
Cerilliant
Chinese Patent Office
US Department of Justice
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.